We’re delighted to announce the launch of a FREE 6th module of #EvidenceEssentials 🎉 It will help you understand when & why a #RapidReview may be conducted, the differences between a rapid and systemic review, & key concepts for assessing quality. buff.ly/3w2aMz2

🎺Our May 29th #ResearchMethods webinar considers the impact of Preprints 📰 🎙️Speaker: Dr. Larissa Shamseer Dr Larissa Shamseer (she/her) 🖱️Registration: ti.ubc.ca/preprints/ #researchmethods #preprints #publishing

ICYMI - #hypertension publication alert🚨 🔍Our The Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn #SystematicReview #prescribing #HighBloodPressure

#CochraneDaily On World Hypertension Day (paho.org/en/campaigns/w…), there are about 100 Cochrane Reviews of hypertension in the The Cochrane Library Cochrane Hypertension #Hypertension

ICYMI - #hypertension publication alert 🔎Our The Cochrane Library review on evening vs morning dosing considers evidence from 2⃣5⃣ studies that randomised more than 3,000 people: tiny.cc/pm-am-htn #SystematicReview #prescribing #HighBloodPressure

Want to be a Cochrane author and contribute to evidence-based healthcare globally? 🌐📚 We have free tools and resources to help you get started! cochrane.org/join-cochrane/…

📢Spotlight Wednesday! 💫Esra Mustafa from Sudan, a medical graduate, research fellow at MSU, and a Cochrane member. 💫Get to know her a bit more on👉👉 @ esratanii

🎺Registration now OPEN for our #BestEvidence for Clinicians annual course! bit.ly/3xmmuVP🎺 ✅highly interactive👥 ☑️engaging expert speakers 🧑🏽‍💻 ✅common + new 💊 tx issues ☑️independent + evidence-based 💯 ✅broad, practical scope 🩺 #CME #MedEd #DrugEvidence24

🆕 in Cochrane Clinical Answers🎺 How do first‐line diuretics compare with other classes of antihypertensive drugs for adults with hypertension? rb.gy/d9j7y2 #SystematicReviews #CochraneClinicalAnswers

En adultos con hipertensión, el tratamiento con diuréticos tiazídicos de primera línea puede dar lugar a menos retiradas por efectos adversos y más beneficios en algunos resultados clínicos, en comparación con los bloqueadores de los canales de calcio, IECA y alfabloqueantes

Ever consider #deprescribing #antihypertensive drugs in older adults? Explore the evidence, benefits, and risks of #deprescribing these drugs in this helpful article from the Australian Prescriber 📖 buff.ly/3RUc5Yb Emily Reeve Danijela Gnjidic Aili Langford

Deprescribing interventions should be tailored to drug class & patient population. Find out the how, what & whys of #deprescribing antihypertensives in frail, older adults in this review, great resource for clinicians developed by Australian colleagues Emily Reeve

Our first-line #diuretics review has been highlighted in Cochrane Clinical Answers🎺 How do first‐line diuretics compare with other classes of antihypertensive drugs for adults with hypertension? rb.gy/d9j7y2 #SystematicReviews #CochraneClinicalAnswers

ICYMI - PRISMA 2020 Webinar recording! 🚨 Matthew Page discusses the 2020 PRISMA Statement - why it matters + preferred reporting for #SystematicReviews bit.ly/3gTB8Jf

#Volunteer with #CochraneEngage and contribute to better health globally! 🎖️ You'll also earn 200 Cochrane Membership points for every task you complete. ➡️ Browse the listed tasks and create your free Cochrane Engage profile today! buff.ly/3imF9bV

A warm welcome to the Cochrane community joining us in Prague for #GES2024 💜

🎉 We're thrilled to announce Cochrane’s new Thematic Groups! futurecochrane.org/newnews/introd… These expert-led, collaborative research teams will focus on specific health and wellbeing areas.

TI Methods Speaker Series webinar: Evaluating study registration & result reporting of trials conducted in 🇨🇦 REGISTER NOW ➡️ ti.ubc.ca/trials Mohsen Alayche discusses his recent paper, which found significant deficiencies in Open Science, capturing global media interest